3858 results for «2303»
3858 results
Newer generation self-expanding platform: technical optimisation for common clinical challenges
05 Dec 2023 – From GulfPCR-GIM 2023
The primary focus of this GulfPCR-GIM 2023 session revolves around pre-procedural planning considerations, valve selection, and managing complex anatomies using both traditional self-expanding valves and the Evolut FX system. Additionally, the session aims to explore the work-up protocol for patients grappling with severe AS and advanced...
Essentials of lifetime management of TAVR patients using novel Myval THV
05 Dec 2023 – From GulfPCR-GIM 2023
Join this GulfPCR-GIM 2023 session to explore the Myval next-generation THV technology, uncovering its unique features, procedural advantages, and clinical benefits, from extensive patient data. Learn also about the CorAlign technique that ensures precise commissural and coronary alignment while preserving coronary access, and gain insights into...
Evidence gap and new indications
05 Dec 2023 – From GulfPCR-GIM 2023
Follow discussions about a 74-year-old patient with NYHA III.IV dyspnea, DM, HTN, paroxismal AF and LVEF 20% to find out more about symptomatic moderate aortic stenosis, and about an 84-year-old patient with dyspnea NYHA III, HTN, no significant CAD, and follow-up for moderate aortic regurgitation, and...
TAVI in cardiogenic shock
19 Nov 2023 – From PCR London Valves 2023
Because TAVI implantation, a routine procedure, is not always a breeze, look at a number of challenging cases, including a case of aortic stenosis complicated by cardiogenic shock, an emergency valve-in-valve TAVI, or a TAVI for left ventricular assist device.
Tricuspid valve interventions - Case studies
19 Nov 2023 – From PCR London Valves 2023
Explore a diverse range of tricuspid valve interventions through various case studies such as the multimodality percutaneous treatment of severe tricuspid regurgitation, Triclip subacute single leaflet detachment, bicaval valve implantation and more.
TAVI in complex scenarios
19 Nov 2023 – From PCR London Valves 2023
What do we mean by "complex scenarios"? When zero-contrast TAVI implantation becomes a good alternative in kidney disease, when TAVI is implanted in a patient with mechanical mitral valve, or when TAVI is implanted in very large annulus with subannular aneurysm, for example!
Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices
20 Nov 2023 – From PCR London Valves 2023
Find out the outcomes of the main studies on the latest-generation valves and devices presented at PCR LV 2023 to better determine their benefits, performance and interest in the treatment of specific aortic pathologies: REACCESS-2 Study, ACURATE Neo2 PMCF post-market registry, OCEAN-TAVI registry, ShortCut Pivotal Study, and...
Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...
19 Nov 2023 – From PCR London Valves 2023
Discover the mitral late-breaking trials which were presented during PCR London Valves 2023:
- One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
- AltaValve transseptal programme update
- Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
- Combined impact of mitral valve gradients and mitral regurgitation reduction...
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
Tricuspid TEER - Part 2
20 Nov 2023 – From PCR London Valves 2023
Valve in valve - TAVI in SAV - Part 1
20 Nov 2023 – From PCR London Valves 2023
Explore innovative approaches in TAVI in SAV with this selection of cases: learn how to manage a degenerated surgical valve using a novel transcatheter heart valve, navigate low-contrast valve-in-valve scenarios in early bioprosthesis failure, witness the adaptability of TAVI valve-in-valve in a severely tortuous and horizontal...
TAVI outcomes - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...
Valve embolism and displacement
20 Nov 2023 – From PCR London Valves 2023
Consult this session to learn innovative strategies and management approaches for valve embolism and displacement: navigate the complexities of challenging severe aortic regurgitation, confront unexpected global myocardial ischemia during TAVI, explore the difficulties of a TAVI procedure in a surgical aortic valve with Evolut FX, and more!
TAVI failure - Mechanisms and management
19 Nov 2023 – From PCR London Valves 2023
Explore various cases that focus on TAVI failure, including the effects of the mechanism of TAVR failure on outcomes after re-intervention, the prognostic impact of patient-prosthesis mismatch and paravalvular leak following TAVI, issues related to bioprosthetic valve dysfunction and much more!
Mitral TEER - Part 2
20 Nov 2023 – From PCR London Valves 2023
Discover compelling cases in TEER with this selection of cases: encounter the complexities of severe mitral regurgitation post-aortic root aneurysm repair, the urgency of percutaneous intervention in acute mitral regurgitation due to papillary muscle rupture, the challenges of acutely decompensated heart failure following complicated surgical AVR,...
Complex tricuspid interventions
20 Nov 2023 – From PCR London Valves 2023
Consult this session to discover a selection of abstracts regarding tricuspid valve procedures: explore the complexities of long-term right heart remodeling after transcatheter tricuspid annuloplasty, witness the journey from pre-clinical studies to the first-in-man experience with MonarQ tricuspid valve replacement, delve into Tripair, an innovative transcatheter spacer...
Second time TAVI (TAV-in-TAV) - Not as simple as it looks
19 Nov 2023 – From PCR London Valves 2023
Although it is still rare, TAV-in-TAV is likely to become more frequent, as TAVI is increasingly implanted in younger patients. Harmonizing data in this area will therefore help to improve outcomes, the quality of which depends on site experience, bearing in mind that for the time...
Innovations in transcatheter tricuspid valve intervention - LIVE case
21 Nov 2023 – From PCR London Valves 2023
Consult this session to discover the new transcatheter treatment strategies, improve your understanding of the clinical indications for intervention, and appreciate the challenges and limitations of tricuspid valve imaging before and during the intervention.
- LIVE case: An 81-year-old woman with permanent AF presents a symptomatic torrential TR with right...
Key questions in aortic valve intervention - Anticoagulation after TAVI - when, and for whom?
21 Nov 2023 – From PCR London Valves 2023
Tune in to this session focused on post-TAVI anticoagulation, where the cases of three TAVI patients are explored. Analyze and determine the optimal antithrombotic strategy for each situation: the first patient in sinus rhythm, the second with atrial fibrillation, and the third with atrial fibrillation undergoing...
